– RESET-RA is the first randomized, sham-controlled, double-blind trial to positively demonstrate the clinical potential of neuroimmune modulation for the treatment of rheumatoid arthritis (RA) – – ...

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib ...

This flagship event brings together the world’s leading experts in rheumatology to discuss groundbreaking research, clinical innovations, and advancements in patient care. EULAR 2024 Congress will ...